These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 2612228

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Transintestinal elimination of ciprofloxacin.
    Rohwedder R, Bergan T, Thorsteinsson SB, Scholl H.
    Chemotherapy; 1990; 36(2):77-84. PubMed ID: 2311444
    [Abstract] [Full Text] [Related]

  • 4. An overview of the pharmacology of intravenously administered ciprofloxacin.
    Drusano GL.
    Am J Med; 1987 Apr 27; 82(4A):339-45. PubMed ID: 3578325
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of ciprofloxacin in liver cirrhosis.
    Ruhnke M, Trautmann M, Borner K, Hopfenmüller W.
    Chemotherapy; 1990 Apr 27; 36(6):385-91. PubMed ID: 2292201
    [Abstract] [Full Text] [Related]

  • 6. The distribution of ciprofloxacin and its metabolites in human plasma, pulmonary and bronchial tissues.
    Bacracheva N, Scholl H, Gerova Z, Chervenakov P, Dobrev P, Vlahov V.
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep 27; 29(9):352-6. PubMed ID: 1937996
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of intravenous ciprofloxacin in normal and renally impaired subjects.
    Shah A, Lettieri J, Blum R, Millikin S, Sica D, Heller AH.
    J Antimicrob Chemother; 1996 Jul 27; 38(1):103-16. PubMed ID: 8858462
    [Abstract] [Full Text] [Related]

  • 8. Transintestinal elimination of ciprofloxacin.
    Rohwedder RW, Bergan T, Thorsteinsson SB, Scholl H.
    Diagn Microbiol Infect Dis; 1990 Jul 27; 13(2):127-33. PubMed ID: 2369809
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Single-dose pharmacokinetics of lomefloxacin in patients with normal and impaired renal function.
    Nilsen OG, Saltvedt E, Walstad RA, Marstein S.
    Am J Med; 1992 Apr 06; 92(4A):38S-40S. PubMed ID: 1316068
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of metronidazole and its metabolites in reduced renal function.
    Bergan T, Thorsteinsson SB.
    Chemotherapy; 1986 Apr 06; 32(4):305-18. PubMed ID: 3731917
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
    Jaehde U, Sörgel F, Reiter A, Sigl G, Naber KG, Schunack W.
    Clin Pharmacol Ther; 1995 Nov 06; 58(5):532-41. PubMed ID: 7586947
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis.
    Stuck AE, Frey FJ, Heizmann P, Brandt R, Weidekamm E.
    Antimicrob Agents Chemother; 1989 Mar 06; 33(3):373-81. PubMed ID: 2499248
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
    Wagenlehner FM, Kinzig-Schippers M, Tischmeyer U, Wagenlehner C, Sörgel F, Dalhoff A, Naber KG.
    Int J Antimicrob Agents; 2006 Jan 06; 27(1):7-14. PubMed ID: 16343856
    [Abstract] [Full Text] [Related]

  • 18. Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function.
    Gasser TC, Ebert SC, Graversen PH, Madsen PO.
    Antimicrob Agents Chemother; 1987 May 06; 31(5):709-12. PubMed ID: 3300537
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.